The potential use of saliva to detect recurrence of disease in women with breast carcinoma
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Approximately 1 woman in every 10 will develop breast cancer in her lifetime. It has been shown that screening for breast cancer can reduce breast cancer mortality. The use of a saliva‐based test could prove to be very useful in post‐operative and/or adjunctive therapy management of breast cancer patients. Methods: The following study was undertaken to establish the possible usefulness of the salivary protein product of the oncogene c‐erbB‐2 in following patients diagnosed with carcinoma of the breast. Included in this study were 25 patients with a mean age of 54 years with varying histological diagnoses and stages of carcinoma of the breast. ELISA assays for c‐erb B‐2 and CA 15–3 were performed on serum and stimulated whole saliva samples collected on all patients prior to any adjunct therapy or surgery and sequentially during therapy. Results: The results of the GLM analyses using marker concentration as the dependent variable and treatment regimen and the serial assessments as independent variables yielded a significant overall model for both the serum (P < 0.007) and salivary (P < 0.017) c‐erb B‐2 markers. The model for serum c‐erb B‐2, however, exhibited a significant difference for treatment regimen (P < 0.001) with the chemotherapy and radiation treatment regimen being significantly different (P < 0.001) from the other treatment therapies. Time (serial assessments) was not significant. The model for the salivary c‐erb B‐2 marker was reversed. Treatment regimen was not significant for this model; however, time (serial assessments) was significant (P < 0.002). The serum and salivary CA 15–3 marker models yielded no significant results. Paired t‐test analyses indicated that only the salivary c‐erb B‐2 concentrations exhibited a significant difference between the pre‐ and post‐therapy values (t = 4.245, P < 0.0001). Additionally, salivary c‐erbB‐2 displayed greater percent reductions across all therapies as compared to the other markers. Conclusions: This preliminary study appears to indicate that c‐erb B‐2 protein expression in saliva may be a very useful diagnostic tool for measuring patient response to chemotherapy and/or surgical treatment of their disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mandel, I. D. (1990) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.1990.tb00809.x · Cited by 305
Cited by
Wearable and flexible electronics for continuous molecular monitoring
Yang, Y., & Gao, W. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00730b · Cited by 1,315
Testosterone-mediated immune functions and male life histories
Muehlenbein, M. P., & Bribiescas, R. G. (2005) · American Journal of Human Biology · doi:10.1002/ajhb.20419 · Cited by 448
Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic Cancer
Zhang, L., Farrell, J. J., Zhou, H., Elashoff, D., Akin, D., Park, N., Chia, D., & Wong, D. T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.010 · Cited by 343
Recent advances in wide bandgap semiconductor biological and gas sensors
Pearton, S. J., Ren, F., Wang, Y.-L., Chu, B. H., Chen, K. H., Chang, C. Y., Lim, W., Lin, J., & Norton, D. P. (2010) · Progress in Materials Science · doi:10.1016/j.pmatsci.2009.08.003 · Cited by 286
Zhang, L., Xiao, H., Karlan, S., Zhou, H., Gross, J., Elashoff, D., Akin, D., Yan, X., Chia, D., Karlan, B., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015573 · Cited by 272
Metadata
- Authors
- Bigler, L. R., Streckfus, C. F., Copeland, L., Burns, R., Dai, X., Kuhn, M., Martin, P., & Bigler, S. A.
- Venue
- Journal of Oral Pathology & Medicine
- Publisher
- Wiley
- Published
- 2002-08
- Volume
- 31
- Issue
- 7
- Pages
- 421-431
- ISSN
- 0300-9777 (ISSN-L)
- 0904-2512
- 1600-0714
- OpenAlex
- W1972026849
- Cited by
- 85
- References
- 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The potential use of saliva to detect recurrence of disease in women with breast carcinoma. https://app.cochat.ai/papers/10.1034/j.1600-0714.2002.00123.x
- The paper
- Bigler, L. R., Streckfus, C. F., Copeland, L., Burns, R., Dai, X., Kuhn, M., Martin, P., & Bigler, S. A. (2002). The potential use of saliva to detect recurrence of disease in women with breast carcinoma. Journal of Oral Pathology & Medicine. https://doi.org/10.1034/j.1600-0714.2002.00123.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.